Syndax Pharma Study Offers Clues that Lung Cancer Treatment Could Benefit ... Xconomy Waltham, MA-based Syndax Pharmaceuticals is reporting data from a mid-stage clinical trial that indicate its lead compound might improve the effectiveness ... Syndax Pharmaceuticals' Entinostat Plus Erlotinib Improves Survival in Select ... Personalized molecular therapy 'effective for advanced lung cancer' |
Tuesday, December 14, 2010
Syndax Pharma Study Offers Clues that Lung Cancer Treatment Could Benefit ... - Xconomy
igoeosysata1533.blogspot.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment